Brand tirzepatide
Sold by OrderlyMeds · Injection, pen · every brand tirzepatide record
Recorded initial charges
First month
$1,498
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Monthly plan (brand) · recorded initial monthly payment | $1,498 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Monthly plan (brand) “Zepbound® (GLP-1/GIP pen) $1,498” | Per month$1,498 | Charged today$1,498 |
Price sources
- Monthly plan (brand) · orderlymeds.com — read September 2026
We earn nothing from this link. It opens OrderlyMeds's website without a paid referral.
History
- September 2026 — $1,498
- September 2026 — $1,498
- September 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | When you sign up, you can cancel any time before the doctor finalizes your prescription, unless you've selected a multi-month plan. Our standard sign-up process includes month-to-month plans as well as multi-month options. |
| Membership | None. “We have no membership fees or hidden costs-what you see is what you pay!” |
Not yet checked: pharmacy and consult fee.
Recorded from orderlymeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Compounded product pages confirm shipments include 'your medication vial,' so compounded entries are recorded as injection-vial; brand pages explicitly say '(GLP-1 pen)' / '(GLP-1/GIP pen)' for Wegovy/Zepbound.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.